Skip to contentRenaud Ronald C JR — IDENIX PHARMACEUTICALS INC insider: 96 transactions · InsiderLensRenaud Ronald C JR
- Director at Ceres, Inc. · on record since Jun 14, 2023
- President & CEO at Ceres, Inc. · on record since Jun 14, 2023
- SVP, CFO, Treasurer, Secretary at KERYX BIOPHARMACEUTICALS INC · on record since Jan 4, 2007
- Director at IDENIX PHARMACEUTICALS INC · on record since Nov 1, 2010
- President & CEO at IDENIX PHARMACEUTICALS INC · on record since Feb 23, 2011
- Director at Kailera Therapeutics, Inc. · on record since Apr 16, 2026
- CEO & President at Kailera Therapeutics, Inc. · on record since Apr 16, 2026
- Director at PTC THERAPEUTICS, INC. · on record since Jun 11, 2014
- Director at Upstream Bio, Inc. · on record since Jun 11, 2026
- Director at Akebia Therapeutics, Inc. · on record since Sep 15, 2014
- Director at Comtrix, Inc. · on record since Dec 18, 2014
- Chief Executive Officer at TRANSGENOMIC INC · on record since Jun 27, 2018
- Director at TRANSGENOMIC INC · on record since Jun 27, 2018
- 10% owner at TRANSGENOMIC INC · on record since Jun 27, 2018
- Director at Atara Biotherapeutics, Inc. · on record since Apr 30, 2020
- Director at INVERNESS MEDICAL INNOVATIONS INC · on record since Mar 25, 2021
Insider trading activity of Renaud Ronald C JR
- Transactions on record
- 96
- since Jan 4, 2007
- Open-market buys
- 3
- $2.1M
- Open-market sells
- 3
- $36.3M
- Companies traded
- 11
- last filing Jun 11, 2026
Figures computed from official regulatory filings — methodology.
Companies where Renaud Ronald C JR has traded
- Upstream Bio, Inc.3 tx · Jun 11, 2026
- Kailera Therapeutics, Inc.4 tx · $200K · Jun 11, 2026
- Ceres, Inc.12 tx · $2M · Aug 5, 2024
- Atara Biotherapeutics, Inc.5 tx · Jun 27, 2022
- INVERNESS MEDICAL INNOVATIONS INC2 tx · Jun 13, 2022
- TRANSGENOMIC INC25 tx · $36.8M · Sep 14, 2021
- Comtrix, Inc.6 tx · Jun 24, 2019
- Akebia Therapeutics, Inc.6 tx · $59.6K · Jun 15, 2018
- PTC THERAPEUTICS, INC.4 tx · $1.1M · Jan 5, 2017
Track record of Renaud Ronald C JR
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of Renaud Ronald C JR
Co-insiders of Renaud Ronald C JR
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
27 tx · $200K · Aug 5, 2014
Baupost Group GP, L.L.C.KERYX BIOPHARMACEUTICALS INC +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 11, 2026 | AwardD | 17,096 | 0.00 USD | $0 | SEC |
| Jun 11, 2026 | ExerciseD | -38,094 | 0.00 USD | $0 | SEC |
| Jun 11, 2026 | Exercise | 38,094 | 5.25 USD | $200K | SEC |
| Apr 20, 2026 | AwardD | 300,000 | 0.00 USD | $0 | SEC |
| Apr 20, 2026 | AwardD | 300,000 | 0.00 USD | $0 | SEC |
| Jun 12, 2025 | AwardD | 17,096 | 0.00 USD | $0 | SEC |
| Oct 15, 2024 | AwardD | 17,096 | 0.00 USD | $0 | SEC |
| Aug 5, 2024 | Other | -83,857 | — | — | SEC |
| Aug 5, 2024 | OtherD | -284,023 | 0.00 USD | $0 | SEC |
| Aug 5, 2024 | OtherD | -215,749 | — | — | SEC |
| Aug 5, 2024 | Other | -160,452 | — | — | SEC |
| Aug 5, 2024 | OtherD | -320,742 | 0.00 USD | $0 | SEC |
| Jan 23, 2024 | AwardD | 284,023 | 0.00 USD | $0 | SEC |
| Dec 21, 2023 | ExerciseD | -160,452 | 0.00 USD | $0 | SEC |
| Dec 21, 2023 | Exercise | 160,452 | — | — | SEC |
| Aug 7, 2023 | Buy | 83,857 | 23.96 USD | $2M | SEC |
| Jun 14, 2023 | AwardD | 160,371 | 0.00 USD | $0 | SEC |
| Jun 14, 2023 | AwardD | 160,452 | 0.00 USD | $0 | SEC |
| Jun 14, 2023 | AwardD | 215,749 | 0.00 USD | $0 | SEC |
| Jun 27, 2022 | AwardD | 31,500 | 0.00 USD | $0 | SEC |
| Jun 27, 2022 | Award | 20,500 | 0.00 USD | $0 | SEC |
| Jun 13, 2022 | AwardD | 13,419 | 0.00 USD | $0 | SEC |
| Dec 23, 2021 | AwardD | 13,419 | 0.00 USD | $0 | SEC |
| Sep 14, 2021 | SellD | -89,996 | 0.00 USD | $0 | SEC |
| Sep 14, 2021 | SellD | -1,071,009 | 0.00 USD | $0 | SEC |